|
|
1.
|
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. MedStar authors:
- Barac, Ana
- Forrestal, Brian J
Year: 2020
Citation: - Circulation. 141(24):2031-2034, 2020 06 16.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alvi RM, Awadalla M, Barac A, Chen CL, Cohen JV, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Jones-O'Connor M, Kirchberger MC, Lyon AR, Mahmood SS, Mahmoudi M, Mandawat A, Murphy SP, Neilan TG, Nohria A, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Shah SP, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Yang EH, Zatarain-Nicolas E, Zhang L, Zlotoff DA, Zubiri L
|
|
|
2.
|
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer. MedStar authors: - Swain, Sandra M MedStar Health
Year: 2024
Citation: - Annals of Oncology. 35(7):630-642, 2024 Jul.
Department: - Associate Dean for Research Development
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Dent R, Andre F, Goncalves A, Martin M, Schmid P, Schutz F, Kummel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortes J
|
